Masimo

Masimo

Medical Equipment Manufacturing

Irvine, CA 119,393 followers

Improving life. Improving patient outcomes and reducing the cost of care.

About us

Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. Our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life For more than 30 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. The result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. Masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. We're looking for people who can, do, and will make a difference. We think you'll like what you see.

Industry
Medical Equipment Manufacturing
Company size
1,001-5,000 employees
Headquarters
Irvine, CA
Type
Public Company
Founded
1989
Specialties
Noninvasive Patient Monitoring Technologies

Locations

Employees at Masimo

Updates

  • View organization page for Masimo, graphic

    119,393 followers

    One of the core tenants of our mission is leveraging innovation to take noninvasive monitoring to new sites and applications. Nowhere is this more evident than with the revolutionary Radius VSM™, a patient-worn vital signs monitor designed to help clinicians prioritize patients based on their needs, not their location in the hospital. This #HLTHUSA, we're excited to showcase how Radius VSM is already helping care teams transform nontraditional environments into continuously monitored care spaces. Visit us at booth 3019, and learn more here: https://ow.ly/mMtQ50TAMeA

    • No alternative text description for this image
  • View organization page for Masimo, graphic

    119,393 followers

    Michelle Brennan, a current member of Masimo’s Board of Directors, has been appointed interim CEO. Michelle was elected to the Board in 2023, and previously served as a senior executive at Johnson & Johnson (“J&J”) for more than 30 years, where she oversaw medical device businesses globally as well as consumer pharmaceutical businesses. At J&J, Michelle successfully scaled multiple businesses to achieve market-leading growth and led efforts to invest in innovation that resulted in successful new product launches. Michelle commented: “I am grateful for the trust of the Board and excited by the opportunity to help Masimo continue to grow and lead as an innovation-focused company. As we go through this transition, the Board and management team are excited to learn from and work with our employees, while focusing on ensuring seamless service and support for our customers.” We are also thrilled to welcome Darlene Solomon, former Chief Technology Officer and Senior Vice President of Agilent Technologies, Inc., and William Jellison, former Chief Financial Officer of Stryker Corporation, to the Masimo Board of Directors following their election at the recent Annual Meeting. Read the full announcement here: Masimo Provides Leadership and Business Updates: https://ow.ly/mPqp50TyvFW

    • No alternative text description for this image
  • View organization page for Masimo, graphic

    119,393 followers

    Today, Mobilize Recovery joined us at HQ to kick off their annual nationwide bus tour, an opportunity to connect with advocates and leaders in the recovery space and learn about breakthrough opioid safety solutions aimed at ending overdose and facilitating recovery. Thank you to everyone who came out to show your support! Together, we can inspire greater health and happiness in our communities. #NationalRecoveryMonth

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • Masimo reposted this

    View profile for Joe Kiani, graphic

    Founder, Chairman & CEO of Masimo, Cercacor & Patient Safety Movement Foundation, Co-founder of A Starting Point

    Today is #WorldPatientSafetyDay, and it’s my honor to speak at the White House Safety Forum about reducing harm across the #healthcare system. We have evidence-based practices that can help us address problems like medication error and opioid overdose, and it’s critically important that we continue collaborating across industries and sharing data to work towards the goal of zero preventable patient deaths. Thank you to the Biden Administration providing a key opportunity to discuss the progress we’ve made with #patientsafety.

    • No alternative text description for this image
  • View organization page for Masimo, graphic

    119,393 followers

    This World Patient Safety Day, Masimo is proud to support the World Health Organization’s focus on improving diagnostic practices to improve patient safety. We invite you to watch below as Masimo’s Chief Medical Officer, Daniel Cantillon M.D., discusses how reliable and accurate monitoring data, aggregated in the most meaningful ways, supports clinicians by delivering insights that can help them identify possible patient deterioration, prioritize patient care needs, and provide bedside care as efficiently, effectively, and proactively as possible. Masimo is committed to helping nurses and doctors around the world improve quality of care, improve patient outcomes, and ultimately, make the hospital environment and overall healthcare system a safer place for all patients. #patientsafety #worldpatientsafetyday#healthforall #worldhealth #masimoinnovates

  • Masimo reposted this

    View profile for Joe Kiani, graphic

    Founder, Chairman & CEO of Masimo, Cercacor & Patient Safety Movement Foundation, Co-founder of A Starting Point

    Thank you Caroline Hyde for having me on Bloomberg to discuss how Masimo’s exciting new partnership with Qualcomm and Google to develop a reference platform will help bring next-generation smartwatches to market with Masimo’s proprietary health monitoring capabilities. At Masimo, we compete based on strong science. With this important partnership, we can ensure that every Android user has access to a scientifically-sound smartwatch that provides accurate and continuous health data, including oxygen levels, pulse rate and hydration. Interview here: https://buff.ly/4deI5y1

    • No alternative text description for this image

Similar pages

Browse jobs

Stock

MASI

NASDAQ

20 minutes delay

$138.83

6.41 (4.841%)

Open
133.14
Low
132.67
High
139.615

Data from Refinitiv

See more info on Bing

Funding

Masimo 4 total rounds

Last Round

Post IPO equity

US$ 750.0M

See more info on crunchbase